BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Palermo E, Acchioni C, Di Carlo D, Zevini A, Muscolini M, Ferrari M, Castiello L, Virtuoso S, Borsetti A, Antonelli G, Turriziani O, Sgarbanti M, Hiscott J. Activation of Latent HIV-1 T Cell Reservoirs with a Combination of Innate Immune and Epigenetic Regulators. J Virol 2019;93:e01194-19. [PMID: 31413127 DOI: 10.1128/JVI.01194-19] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Snopková S, Husa P, Kozáková Š. Is pharmacological eradication of HIV possible? Klin Farmakol Farm 2022;36:93-100. [DOI: 10.36290/far.2022.015] [Reference Citation Analysis]
2 Olson RM, Gornalusse G, Whitmore LS, Newhouse D, Tisoncik-Go J, Smith E, Ochsenbauer C, Hladik F, Gale M Jr. Innate immune regulation in HIV latency models. Retrovirology 2022;19:15. [PMID: 35804422 DOI: 10.1186/s12977-022-00599-z] [Reference Citation Analysis]
3 Mohammad Yaseen M, Mohammad Abuharfeil N, Darmani H. T-cell evasion and invasion during HIV-1 infection: The role of HIV-1 Tat protein. Cellular Immunology 2022;377:104554. [DOI: 10.1016/j.cellimm.2022.104554] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Kleinman AJ, Pandrea I, Apetrei C. So Pathogenic or So What?-A Brief Overview of SIV Pathogenesis with an Emphasis on Cure Research. Viruses 2022;14:135. [PMID: 35062339 DOI: 10.3390/v14010135] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Acchioni C, Palermo E, Sandini S, Acchioni M, Hiscott J, Sgarbanti M. Fighting HIV-1 Persistence: At the Crossroads of "Shoc-K and B-Lock". Pathogens 2021;10:1517. [PMID: 34832672 DOI: 10.3390/pathogens10111517] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
6 Gokavi J, Sadawarte S, Shelke A, Kulkarni-Kale U, Thakar M, Saxena V. Inhibition of miR-155 Promotes TGF-β Mediated Suppression of HIV Release in the Cervical Epithelial Cells. Viruses 2021;13:2266. [PMID: 34835072 DOI: 10.3390/v13112266] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Alto A, Natesampillai S, Chandrasekar AP, Krogman A, Misra A, Shweta F, VanLith C, Yao JD, Cummins NW, Badley AD. The Combination of Venetoclax and Ixazomib Selectively and Efficiently Kills HIV-Infected Cell Lines but Has Unacceptable Toxicity in Primary Cell Models. J Virol 2021;95:e00138-21. [PMID: 33827940 DOI: 10.1128/JVI.00138-21] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
8 Jeremiah SS, Miyakawa K, Matsunaga S, Nishi M, Kudoh A, Takaoka A, Sawasaki T, Ryo A. Cleavage of TANK-Binding Kinase 1 by HIV-1 Protease Triggers Viral Innate Immune Evasion. Front Microbiol 2021;12:643407. [PMID: 33986734 DOI: 10.3389/fmicb.2021.643407] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
9 Singh V, Dashti A, Mavigner M, Chahroudi A. Latency Reversal 2.0: Giving the Immune System a Seat at the Table. Curr HIV/AIDS Rep 2021;18:117-27. [PMID: 33433817 DOI: 10.1007/s11904-020-00540-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
10 Berthelot JM, Lioté F, Maugars Y, Sibilia J. Lymphocyte Changes in Severe COVID-19: Delayed Over-Activation of STING? Front Immunol 2020;11:607069. [PMID: 33335532 DOI: 10.3389/fimmu.2020.607069] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 13.5] [Reference Citation Analysis]
11 Takahama S, Yamamoto T. Pattern Recognition Receptor Ligands as an Emerging Therapeutic Agent for Latent HIV-1 Infection. Front Cell Infect Microbiol 2020;10:216. [PMID: 32457851 DOI: 10.3389/fcimb.2020.00216] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]